🗂️

Archived grant — no longer open

This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.

grant

Acylcarnitine Metabolism in Ovarian Cancer Chemoresistance

Organization UNIVERSITY OF PITTSBURGH AT PITTSBURGHLocation PITTSBURGH, UNITED STATESPosted 1 Jan 2025Deadline 1 Sept 2025 ⚠️
NIHUS FederalResearch GrantFY2025AblationAcetyl CarnitineAcetyl CoAAcetyl Coenzyme AAcetylationAcetylcarnitineAtlasesAutomobile DrivingBreast CancerCDDPCancer PatientCancersCarnitineChemoresistanceCis-diammine-dichloroplatinumCis-diamminedichloridoplatinumCis-diamminedichloro Platinum (II)Cis-dichloroammine Platinum (II)Cis-platinous Diamine DichlorideCis-platinum IICis-platinum II Diamine DichlorideCisplatinCisplatinaCisplatinumClinicalCysplatynaDNA DamageDNA Damage RepairDNA InjuryDNA RepairDataDichlorodiammineplatinumDietDietary InterventionDiseaseDisorderDrug TherapyEnzyme GeneEnzymesEpithelial ovarian cancerFemale Reproductive CancerFutureGeneticGoalsGynecologic CancerGynecological CancerHeterograftHeterologous TransplantationHistone AcetylationIntermediary MetabolismInterventionKnowledgeMalignant Breast NeoplasmMalignant Female Reproductive System NeoplasmMalignant Gynecologic NeoplasmMalignant Gynecologic TumorMalignant NeoplasmsMalignant Ovarian NeoplasmMalignant Ovarian TumorMalignant TumorMalignant Tumor of the Female Reproductive SystemMalignant Tumor of the OvaryMalignant neoplasm of ovaryMalignant neoplasm of prostateMalignant prostatic tumorMapsMediatingMetabolicMetabolic PathwayMetabolic ProcessesMetabolismModelingMolecularNGS MethodNGS systemNuclearNutrition InterventionsNutritional InterventionsOvarian Serous AdenocarcinomaOvarian Serous CarcinomaOvary CancerPARP InhibitorPARP-1 inhibitorPARPiPathway interactionsPatientsPeyrone's ChloridePeyrone's SaltPharmacological TreatmentPharmacotherapyPlatinumPlatinum BlackPlatinum DiamminodichloridePoly(ADP-ribose) Polymerase InhibitorPoly(ADP-ribose) polymerase 1 inhibitorPost-Translational Modification Protein/Amino Acid BiochemistryPost-Translational ModificationsPost-Translational Protein ModificationPost-Translational Protein ProcessingPosttranslational ModificationsPosttranslational Protein ProcessingProcessProstate CAProstate CancerProstate malignancyProtein ModificationPt elementResearchResistanceS-acetate Coenzyme ASerous Adenocarcinoma of the OvarySerous Carcinoma of the OvarySiteSourceTestingTherapeuticUnscheduled DNA SynthesisWorkXenograftXenograft procedureXenotransplantationacyl groupacylcarnitinechemoresistantchemotherapy resistancechemotherapy resistantcis dichlorodiammineplatinumcis platinum compoundcis-Diaminedichloroplatinumcis-Diamminedichloroplatinumcis-Diamminedichloroplatinum(II)cis-Dichlorodiammineplatinum(II)cis-Platinumdiet interventiondietarydietsdrivingdrug interventiondrug treatmentgynecologic malignancygynecological malignancyhomologous recombinationimprovedinsightknock-downknockdownmalignancymalignant breast tumormouse modelmurine modelneoplasm/cancernew approachesnew drug targetnew druggable targetnew pharmacotherapy targetnew therapeutic targetnew therapy targetnext gen sequencingnext generation sequencingnextgen sequencingnovel approachesnovel drug targetnovel druggable targetnovel pharmacotherapy targetnovel strategiesnovel strategynovel therapeutic targetnovel therapy targetovarian cancerpathwaypharmaceutical interventionpharmacologicpharmacological interventionpharmacological therapypharmacology interventionpharmacology treatmentpharmacotherapeuticsrepairrepairedresistantresponsestandard of caretherapeutic outcometherapy outcometraffickingtumoruptakexeno-transplantxeno-transplantation

Applications closed.

Description preview

PROJECT SUMMARY ABSTRACT
High-grade serous ovarian carcinoma (HGSOC) is the most prevalent histosubtype of epithelial ovarian cancer.
Therapy for HGSOC relies on DNA damaging agents, with a high percentage of cancers having de novo or
acquired chemoresistance due in part to homologous recombination (HR) proficiency. Our preliminary data has…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →

Explore more

📍 More grants in UNITED STATES🏷 More NIH opportunities🏷 More US Federal opportunities🏷 More Research Grant opportunities🏢 All nih_reporter opportunities